*Applies to a deviation of less than 1%; not applicable for per-share numbers.
The current average analyst rating on the shares is "strong buy" and the breakdown of recommendations is 6 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"
The average consensus recommendation for the healthcare facilities & services peer group is "buy."
Wall Street's median 12-month price target for Brookdale Senior Living Inc is $18.75, about 31.9% above its August 7 closing price of $14.22
BKD•
